Condition: Hematologic Diseases
Interventions: Drug: Interleukin-2 (100,000 international units); Drug: Interleukin-2 (200,000 international units)
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified September 2011
Feeds
4628 items (4628 unread) in 80 feeds
Acinar Cell Carcinoma
(29 unread)
Acinic Cell Carcinoma
(33 unread)
Adenoid Cystic Carcinoma
(57 unread)
Adrenal Gland Cancer
(335 unread)
Ampulla Of Vater
(14 unread)
Anal Cancer
(252 unread)
Angiosarcoma
(73 unread)
Appendix Cancer
(35 unread)
Bile Duct Cancer
(386 unread)
Brain and CNS
(1151 unread)
Carcinoid
(143 unread)
Endocrine/Neuroendocrine
(291 unread)
Gall Bladder Cancer
(227 unread)
Hemangioendothelioma
(23 unread)
Hepatoblastoma
(31 unread)
Pancreas
(45 unread)
Phyllodes
(21 unread)
PMP and Mucinous Tumors
(19 unread)
Rhabdomyosarcoma
(191 unread)
Sarcoma
(602 unread)
Twitter Pals
(670 unread)
Trial - CNS Tumor (5 unread)
-
Ultra Low Dose Interleukin-2 in Healthy Volunteers
Posted: September 30th, 2011, 8:00am MDT
-
Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL
Posted: September 28th, 2011, 8:00am MDT
Condition: Mantle Cell Lymphoma
Interventions: Drug: Rituximab; Drug: High dose Ara-C; Drug: Dexamethasone; Drug: Bortezomib
Sponsors: European Mantle Cell Lymphoma Network; Dr. M. Dreyling (co-chairman); Klinikum der Universitaet Muenchen, Grosshadern; ClinAssess GmbH, Leverkusen; GELARC Service de Pharmacovigilance, Pierre Benite
Recruiting - verified May 2012 -
Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients
Posted: September 21st, 2011, 8:00am MDT
Condition: Chemotherapy-Induced Nausea and Vomiting
Interventions: Drug: Palonosetron; Drug: Palonosetron; Drug: Ondansetron
Sponsors: Helsinn Healthcare SA; Helsinn Healthcare SA
Recruiting - verified May 2012 -
Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide
Posted: September 9th, 2011, 8:00am MDT
Condition: Myeloma
Interventions: Drug: Pomalidomide; Drug: Dexamethasone; Drug: Cyclophosphamide
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; Celgene Corporation
Recruiting - verified May 2012 -
A Study to Evaluate the Use of Chloroquine in Combination With VELCADE and Cyclophosphamide in Patients With Relapsed and Refractory Multiple Myeloma
Posted: September 8th, 2011, 8:00am MDT
Condition: Multiple Myeloma
Interventions: Drug: Cyclophosphamide; Drug: Velcade; Drug: Chloroquine
Sponsors: New York University School of Medicine; New York University School of Medicine; Millennium Pharmaceuticals, Inc.
Recruiting - verified April 2012